8-K: Israel Acquisitions Corp. Faces Nasdaq Delisting

Israel Acquisitions Corp. received a delist determination from Nasdaq due to failure to meet the minimum market value requirement, though it still intends to complete its business combination.

Summary

• Israel Acquisitions Corp. (ISRL) received a delist determination letter from Nasdaq on November 25, 2025.
• The delisting is due to the company's failure to regain compliance with Nasdaq Listing Rule 5450(b)(2)(A), which requires a minimum market value of listed securities of at least $50 million.
• The company was initially notified of this deficiency on May 28, 2025, and had until November 24, 2025, to regain compliance.
• Unless an appeal is filed by December 2, 2025, the company's securities would be delisted on December 4, 2025.
• Following delisting, the company's securities (ISRL, ISRLU, ISRLW) will be eligible to trade on the OTC Markets.
• Despite the delisting, the company intends to proceed with its previously announced business combination with Gadfin Ltd. to form NewPubco.
• The company and Gadfin plan to apply for NewPubco's securities to be listed on Nasdaq after the business combination is completed.

Sentiment

Score: 3

Explanation: The delisting from Nasdaq is a significant negative event, indicating a failure to meet basic listing requirements and likely leading to reduced liquidity and share price pressure. While the intent to complete the business combination and relist is a positive signal, it is a future event with inherent risks, and the immediate impact is negative.

Positives

• The company explicitly states its intention to complete the announced business combination with Gadfin Ltd.
• There is a plan to apply for NewPubco's securities to be listed on Nasdaq following the consummation of the Business Combination.

Negatives

• The company received a delist determination letter from Nasdaq for failing to meet the minimum market value of listed securities requirement.
• Trading on the OTC Markets post-delisting may result in a very limited market, adversely affecting the trading price and potentially lacking sufficient trading volume for an efficient market.
• There is no assurance that securities will continue to trade on the OTC market or that broker-dealers will provide public quotes.

Risks

• The expected filing of Form 25-NSE by Nasdaq, formalizing the delisting.
• Uncertainty regarding the impact of its securities trading on the OTC Markets, including potential for a very limited market, adverse effect on trading price, and insufficient trading volume.
• Risk that the combined company's securities may not be successfully listed on Nasdaq following the Business Combination.
• Risks associated with the timing of the closing of the proposed business combination, including conditions not being satisfied or waived, or the closing not occurring at all.
• Potential for legal proceedings that may be instituted against the parties and others related to the proposed transactions.
• The occurrence of any event, change, or circumstance that could lead to the termination of the proposed business combination.

Future Outlook

The company intends to complete its business combination with Gadfin Ltd. and plans to apply for the combined company's securities (NewPubco) to be listed on Nasdaq post-merger. However, there are significant risks associated with the delisting, trading on OTC Markets, and the successful completion and subsequent listing of the business combination.

Management Comments

• "Notwithstanding the delisting of the Company’s securities from Nasdaq, it remains the intention of the Company to complete the announced business combination pursuant to that certain Business Combination Agreement, dated as of January 26, 2025... by and among the Company and Gadfin Ltd."
• "In connection therewith, the Company and Gadfin plan to apply to have NewPubco’s securities listed on the Nasdaq following the consummation of the Business Combination."

Industry Context

This event highlights the challenges faced by Special Purpose Acquisition Companies (SPACs) in maintaining listing requirements, especially the minimum market value, often due to market sentiment or delays in completing de-SPAC transactions. Delisting to OTC Markets is a common consequence for SPACs that fail to meet these requirements, potentially impacting investor liquidity and valuation. The intent to complete the business combination and relist the combined entity on Nasdaq is a typical strategy to mitigate the negative impact of a SPAC's delisting.

Legal Proceedings

• The outcome of any legal proceedings that may be instituted against the parties and others related to the proposed transactions is a risk factor.

Stakeholder Impact

• Shareholders: Will experience reduced liquidity and potentially adverse trading prices as securities move to the OTC Markets. Their voting decision for the business combination is crucial.
• Investors: Face increased risk due to delisting and uncertainty surrounding the future listing of the combined entity.
• Company Management: Must navigate the delisting process, manage the business combination, and work towards a future Nasdaq listing for NewPubco.

Next Steps

• The company has until December 2, 2025, to request a hearing panel appeal of the delist determination.
• If no appeal, Nasdaq will file a Form 25-NSE with the SEC to complete the delisting on December 4, 2025.
• Following delisting, the company's securities will be eligible to trade on the OTC Markets.
• The company intends to complete the business combination with Gadfin Ltd.
• The company and Gadfin plan to apply for NewPubco's securities to be listed on Nasdaq after the business combination.
• Investors and security holders are urged to read the definitive proxy statement/prospectus when available for the Business Combination.

Key Dates

Recommendation

The immediate delisting from Nasdaq is a severe negative event, typically leading to a significant drop in liquidity and share price. While the company intends to complete a business combination and relist, this is a future, uncertain event. The current situation presents substantial downside risk for existing shareholders due to the move to the OTC Markets, making a "sell" recommendation prudent for risk-averse investors seeking to avoid further potential losses and illiquidity.

Keywords

Nasdaq delisting, ISRAEL ACQUISITIONS CORP, ISRL, 8-K filing, SPAC, Business Combination, Gadfin Ltd., OTC Markets, MVLS Requirement, corporate governance, securities trading